Teladoc Health Q3 EPS USD -0.15

By Reuters News

Oct 28 (Reuters) - Teladoc Health Q3 adjusted EBITDA USD 79.358 million vs. IBES estimate USD 67.8 million.

  • Q3 net income USD -26.934 million
  • Q3 revenue USD 605.102 million vs. IBES estimate USD 588.5 million
  • Q3 basic EPS USD -0.15
  • outlook Q4 adjusted EBITDA USD 74-100 million vs. IBES estimate USD 87.1 million
  • outlook FY adjusted EBITDA USD 277-303 million vs. IBES estimate USD 278.9 million
  • outlook Q4 EPS USD -0.23 to -0.03
  • outlook FY revenue USD 2,395-2,441 million vs. IBES estimate USD 2,406 million
  • outlook FY EPS USD -0.95 to -0.75
  • outlook Q4 revenue USD 569-615 million vs. IBES estimate USD 597.4 million

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.